TMONEUTRAL

Gross Margin

40.3%

Higher than 15% of Healthcare sector peers

Updated 166h ago

Sector Performance

15th percentile

TMO

40.3%

Sector Median

68.9%

Sector Avg

-20.2%

📊

Deep Analysis

Thermo Fisher Scientific Inc. (TMO) has a Gross Margin of 40.3% as of June 2026.

This places TMO in the 15th percentile of the Healthcare sector, which has a median Gross Margin of 68.9% and a sector average of -20.2%. TMO's Gross Margin is 41.5% below the sector median. In context: Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

Frequently Asked Questions

What does the Gross Margin tell investors about TMO?

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

How is the Gross Margin calculated?

Gross Margin is calculated as: Gross Profit / Revenue.

How does TMO's Gross Margin compare to its sector?

TMO's Gross Margin of 40.3% compares to a Healthcare sector median of 68.9%, placing it in the 15th percentile.

Who are TMO's closest peers by Gross Margin?

The closest Healthcare peers by Gross Margin include: BLUE (68.4%), AMGN (68.2%), TDOC (67.8%), TECH (66.9%), NTRA (64.8%).

The Formula

Gross Profit / Revenue

Why It Matters

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.